A2A Adenosine Receptors and Equine Sepsis

Award Information
Agency:
Department of Agriculture
Branch
n/a
Amount:
$296,000.00
Award Year:
2006
Program:
SBIR
Phase:
Phase II
Contract:
2006-33610-17725
Agency Tracking Number:
2003-00471
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
Adenosine Therapeutics, LLC
1670 Discovery Dr., Ste. 212, Charlottesville, VA, 22911
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
Robert Thompson
(434) 951-9484
rdt@adenrx.com
Business Contact:
Robert Capon
CEO
(434) 220-9400
rob@adenrx.com
Research Institution:
n/a
Abstract
Endotoxemia (Sepsis) affects horses of all breeds and ages and is the leading causes of death in adult horses and foals. Consequently, its economic impact on the equine industry in the United States is devastating. This project seeks to develop new treatments for this disease.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government